Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Syndax Pharmaceuticals
Research
A SMRT new target for male contraceptives works in mice
A drug with past life as a potential anti-cancer agent might someday have a new job as "the pill" for men, new data in mice suggest.
Helen Floersh
Feb 22, 2024 3:35pm
Syndax slips as pivotal cancer trial stopped early for efficacy
Oct 2, 2023 9:40am
Ex-J&J research chief lands at FogPharma—Chutes & Ladders
Mar 31, 2023 9:30am
Roche taps new North American diagnostics chief—Chutes & Ladders
Dec 9, 2022 9:30am
Syndax, Incyte pen chronic graft-versus-host disease collab
Sep 27, 2021 7:25am
Syndax cans FDA filing for lead drug after breast cancer bust
May 22, 2020 9:00am
